Purchase Order 75N91019P00718
- Not listed
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $213,364.20 firm-fixed-price purchase order to Becton, Dickinson And Company (BD) for service and maintenance of a BD FACSymphony A3 flow cytometer located in San Jose, California. The contract has a completion date of February 29, 2024 and was awarded on February 26, 2019. The contract was not set aside for a specific business type. BD, a global medical technology company, provides a...
- This federal contract award was made by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Becton, Dickinson and Company's IDS division, operating as BD Diagnostic Systems. The $698,027.48 firm fixed price purchase order was awarded on August 29, 2018 to provide a BD Biosciences FACSymphony, or equal, fluorescent analytical flow cytometer. This equipment is being procured to support the National Cancer Institute's research programs. The...
- The National Institutes of Health (NIH) awarded a delivery order valued at $241,431 to Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, for a BD Flow Cytometer System. The contract was awarded on September 1, 2004, with an ultimate completion date of September 30, 2004, and represents a firm fixed-price procurement with no small business set-aside. Performance will take place in Maryland. BD Biosciences is a global medical technology manufacturer...
- This is a $600,264.33 firm-fixed-price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Becton, Dickinson and Company (BD), a manufacturer of medical devices, instruments, reagents, and related products. The contract is for the delivery of a BD FACSymphony A-5 30-color flow cytometer, a specialized laboratory instrument used for advanced cellular analysis. BD, through its IDS division operating...
- This firm fixed-price contract was awarded by the Department of Health and Human Services National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Becton, Dickinson and Company (BD) to provide a new flow cytometer system configured per the quote. The contract has a potential value of $772,218.37 and a completion date of February 9, 2023. The contract was awarded on September 18, 2019 and was not set aside for any specific business type. BD is a...
- This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $100,792.44. The contract requires BD to provide all labor, material, and equipment necessary to maintain and perform preventive maintenance on a BD FACSymphony A3 flow cytometry analyzer and its five lasers. The award has no set-aside designation, indicating it was competed on a full and open basis. BD is a...
- This purchase order awards Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division $580,350.05 to deliver one Becton Dickson FACSympony A5 flow cytometer or equivalent to the National Cancer Institute's Center for Cancer Research Vaccine Branch located in Bethesda, Maryland by January 28, 2021. The solicitation sought quotes for a replacement high-parameter flow cytometer with specific laser and detector capabilities to support the National Institutes of Health National...
- The National Cancer Institute awarded a $700,000 firm fixed-price purchase order to Becton, Dickinson and Company (operating as BD Biosciences) on September 16, 2024, for equipment lease, maintenance services, and consumables supporting the NCI Flow Cytometry Unit in Bethesda, Maryland. This non-compete procurement fulfills the Laboratory of Pathology Flow Cytometry Laboratory's need for BD-owned flow cytometry instruments with warranty and preventive maintenance coverage, along with...
- The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a $251,775.82 firm fixed-price purchase order to Becton, Dickinson And Company (BD), a global medical technology company, for a FACSMELODY flow cytometer. This award does not have a set-aside designation. BD Biosciences, a division of BD, focuses on providing instruments, reagents, and services that support biomedical research and clinical applications through...
- This federal contract award to Becton, Dickinson and Company (BD) for $209,518.88 is for the procurement of one Becton Dickinson FACSLyric flow cytometer in support of the U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Molecular Imaging Program (MIP). The flow cytometer will replace an existing 10-year-old instrument and is an essential piece of equipment for the MIP's pre-clinical...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a firm fixed-price purchase order to Becton, Dickinson and Company (BD) to acquire a BD FACSymphony A3 flow cytometer analyzer, a five-laser, 23-color system. The contract, which did not have a set-aside designation, was awarded on September 20, 2019 with a completion date of January 20, 2020 and a potential value of $359,443.75. BD Biosciences, a division of BD focused on biomedical research and clinical applications, will provide the flow cytometer to support the work of the National Cancer Institute in San Jose, California. BD is a global medical technology company that has extensive experience supporting U.S. government agencies, including NIH and the Department of Veterans Affairs, through the supply of specialized biomedical equipment, reagents, and services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $359.4k | 9/20/19 |